Preoperative and Postoperative (1st and 3rd Month) Metabolic Data of Patients Who Underwent Bariatric Surgery

dc.contributor.authorKutbay, Nilufer Ozdemir
dc.contributor.authorYurekli, Banu Sarer
dc.contributor.authorOzisik, Hatice
dc.contributor.authorAltun, Ilker
dc.contributor.authorSuner, Asli
dc.contributor.authorSimsir, Ilgin Yildirim
dc.contributor.authorFirat, Ozgur
dc.contributor.authorErdogan, Mehmet
dc.contributor.authorCetinkalp, Sevki
dc.contributor.authorOzgen, Gokhan
dc.contributor.authorSaygili, Fusun
dc.date.accessioned2019-10-27T22:27:38Z
dc.date.available2019-10-27T22:27:38Z
dc.date.issued2015
dc.departmentEge Üniversitesien_US
dc.description.abstractPurpose: The growing prevalence of obesity has become a major concern. The efficacy of medical treatment, diet and behavior therapy in morbidly obese patients is limited. Obesity surgery is a treatment option for selected morbidly obese patients. Material and Method: Data of 47 patients (n=39 women, 8 men) who underwent bariatric surgery were investigated. Results: Out of 47 patients, 20 underwent Roux-en-Y gastric bypass (RYGB) (43%) and 27 had sleeve gastrectomy (SG) (57%). The mean age of the patients was 37+/-9.5 (19-59) years. 17% of patients were men and 83% were women. In the analysis of data on weight that could be found for 31 out of 47 patients, we detected preoperative and postoperative (1st and 3rd month) mean weight values as 125.4+/-15.9 kg, 112.7+/-13.2 kg (p<0.001) and 100.9+/-17.5 kg (p<0.001), respectively. In addition, the analysis of the data on mean fasting plasma glucose (FPG) levels which could be found for 23 out of 47 patients, showed us that preoperative and postoperative (1st and 3rd month) FPG levels were 100.9+/-17.5 mg/dL, 91.6+/-10.9 mg/dL (p=0.03) and 87.3+/-2.0 mg/dL, respectively. Only 1 patient had diabetes before the surgery. In the RYGB group, the mean change in weight was 12.4+/-5.5 kg in the 1st month and 22.2+/-8.6 kg in the 3rd month (compared to the weights in the preoperative period). Moreover, in the SG group, the mean change in weight was 13.7+/-4.5 kg in the 1st month and 23.4+/-5.8 kg in the 3rd month. No statistically significant difference was found between the weight changes in the 1st and the 3rd month as for surgery types. Discussion: After bariatric surgery, significant loss in weight and reduction in FPG occurred in short-term.en_US
dc.identifier.doi10.4274/tjem.2717
dc.identifier.endpage18en_US
dc.identifier.issn1301-2193
dc.identifier.issue1en_US
dc.identifier.startpage14en_US
dc.identifier.urihttps://doi.org/10.4274/tjem.2717
dc.identifier.urihttps://hdl.handle.net/11454/50729
dc.identifier.volume19en_US
dc.identifier.wosWOS:000362601400004en_US
dc.identifier.wosqualityN/Aen_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.language.isoenen_US
dc.publisherGalenos Yayinciliken_US
dc.relation.ispartofTurkish Journal of Endocrinology and Metabolismen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectBariatric surgeryen_US
dc.subjectobesityen_US
dc.subjectweight changeen_US
dc.titlePreoperative and Postoperative (1st and 3rd Month) Metabolic Data of Patients Who Underwent Bariatric Surgeryen_US
dc.typeArticleen_US

Dosyalar